Inventiva (IVA) has received a new Hold rating, initiated by UBS analyst, Eliana Merle. Eliana Merle’s rating is based on the promising ...

UBS initiated coverage of Inventiva (IVA) with a Neutral rating and $3 price target The firm thinks the company’s pan-PPAR agonist ...